17 July 2024 in Journal of Pre-Clinical and Clinical Research
Introduction and objective: Chronic kidney disease (CKD) is a major health issue worldwide affecting 10–14% of the globe’s population, with a climbing trend. CKD is associated with a variety of factors, including obesity, which has grown increasingly prevalent and adds to the pathogenesis...
31 December 2023 in OphthaTherapy. Therapies in Ophthalmology
Uveal melanoma is the most common primary intraocular malignancy. In Europe, the incidence of uveal melanoma is approximately 8 cases per million people per year. In about 50% of cases, uveal melanoma metastasizes. Scientific papers on uveal melanoma published between 1 January 2018 – 1 March 2023, available in the PubMed database were analysed. Currently, methods such as enucleation, transpupillary thermotherapy, photodynamic therapy, eye plaque brachytherapy, proton beam therapy and stereotactic surgery are used to treat this cancer. In this paper we summarize the current knowledge about the classic treatment methods and the promising novel ones.
5 May 2026 in Medical Science Pulse
Background: Ovarian cancer remains one of the most lethal gynecologic malignancies, ranking eighth in both incidence and mortality among women. Its asymptomatic early course and nonspecific symptoms often lead to late-stage diagnosis and a poor prognosis.Aim of the study: The aim of this article is to present the current status of immunotherapy in the treatment of ovarian cancer.Material and methods: A narrative review of the available literature was conducted, focusing on recent trials and studies evaluating immunotherapeutic approaches in ovarian cancer.Results: Standard treatment for ovarian cancer includes cytoreductive surgery followed by platinum-based chemotherapy; however, recurrence and platinum resistance remain major clinical challenges. In recent years, immunotherapy has emerged as an actively investigated treatment strategy, particularly in platinum-resistant disease. Various strategies are under investigation, including immune checkpoint inhibitors, CAR T-cell therapies, and oncolytic viruses. PD-1/PD-L1 inhibitors have shown potential efficacy, especially in tumors expressing PD-L1, which may serve as a predictive biomarker for treatment response.Conclusions: Despite promising research results, the clinical benefits of immunotherapy in ovarian cancer remain limited. Future studies should focus on identifying reliable predictive biomarkers, optimizing combination therapies, and improving treatment efficacy while maintaining an acceptable safety profile.
4 June 2026 in Quality in Sport
Background. Dysmenorrhea, one of the most common gynecological problems, significantly reduces patients’ quality of life. Standard therapy is based on the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal contraceptives, however it is associated with adverse effects. Alternative treatment methods are being sought, including vitamin supplementation, particularly vitamin D and E. Aim. The aim of this study was to evaluate the role of vitamin D and E supplementation in dysmenorrhea. Material and methods. In March 2026, the PubMed database was searched. The following strategies were applied: (Dysmenorrhea OR "menstrual pain") AND ("Vitamin D" OR cholecalciferol OR "vitamin D3" OR "25-hydroxyvitamin D" OR 25(OH)D) and (Dysmenorrhea OR "menstrual pain") AND ("Vitamin E" OR tocopherol OR alpha-tocopherol). Studies published in English within the last 10 years were included. After screening titles and abstracts, full-text analysis was performed. Ultimately, 12 publications were included. Results. An association between vitamin D levels and the severity of menstrual pain was demonstrated, and supplementation led to symptom reduction. Beneficial effects were also observed with the combined use of vitamins D and E, suggesting a possible synergistic effect. The results regarding vitamin E are inconsistent - some studies indicate its effectiveness, particularly in combination with other compounds (e.g., omega-3 fatty acids or vitamin C), which may be related to its antioxidant properties. However, not all studies confirm this relationship. Conclusions. Vitamin D and E supplementation may be an effective adjunct in the treatment of dysmenorrhea. However, further studies on larger populations are required.